Center for Biological Diversity
EPANonrulemakingEPA-HQ-OPP-2015-0767

Brodifacoum Registration Review

RIN
Last modified
Oct 22, 2025
Comment window
closed 1261d ago
Center for Biological Diversity filings
4

Activity

Center for Biological Diversity filed 4 comments on this docket between Aug 29, 2016 and Mar 1, 2023. 57 other organizations filed here. The comment window closed 1261d ago.

What Center for Biological Diversity filed (4)

Mar 1, 2023· Comment submitted by Center for Biological Diversity· EPA-HQ-OPP-2015-0767-0395

Filed on regulations.gov — full text not in the inline record.

Jul 29, 2020· Comment submitted by Jonathan Evans, Environmental Health Legal Director & Senior Attorney on behalf of Center for Biological Diversity· EPA-HQ-OPP-2015-0767-0056

These comments are submitted on behalf of the Center for Biological Diversity on the Draft Human Health and/or Ecological Risk Assessments for Several Rodenticides.

Oct 20, 2016· Comment submitted by Jonathan Evans, Environmental Health Legal Director, Center for Biological Diversity (CBD) et al.· EPA-HQ-OPP-2015-0767-0044

See attached files submitted on behalf of the Center for Biological Diversity, 28 other conservation, public health, and animal welfare organizations, and over 24,000 U.S. residents regarding the need to immediately cancel all general use registrations for Second Generation Anticoagulant Rodenticides ("SGARs") and classify any remaining registrations as restricted use products that are available only for use as a last resort during demonstrated public health or environmental emergencies, which only permit the use of these rodenticides when there is a recognized emergency condition such as an urgent, non-routine situation that requires the use of a pesticide to address public health threat or significant risk to endangered or threatened species, beneficial organisms, or the environment.

Aug 29, 2016· Mass Comment Campaign sponsored by Center for Biological Diversity (web) (24,146)· EPA-HQ-OPP-2015-0767-0041

See attached files submitted on behalf of the Center for Biological Diversity, 28 other conservation, public health, and animal welfare organizations, and over 24,000 U.S. residents regarding the need to immediately cancel all general use registrations for Second Generation Anticoagulant Rodenticides ("SGARs") and classify any remaining registrations as restricted use products that are available only for use as a last resort during demonstrated public health or environmental emergencies, which only permit the use of these rodenticides when there is a recognized emergency condition such as an urgent, non-routine situation that requires the use of a pesticide to address public health threat or significant risk to endangered or threatened species, beneficial organisms, or the environment.

Abstract

For further information contact: Steven R. Peterson at Peterson.StevenR@epa.gov or (202) 566-2218.

View on regulations.gov →